KR
Khosla Rachna Directrice du Développement Commercial
Other F
Insider track record Executive Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Khosla Rachna, Directrice du Développement Commercial. Director active across 1 company, notably AMGEN INC. In total, 36 disclosures have been logged. Split: 0 buy · 3 sells. Total volume traded: €750k. Activity tracked since 5 November 2021. The latest transaction was disclosed on 2 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations 36 total
● SVP, Business Development · Executives · 2 May 2026 · AMGEN INC 117 shares @ US$329.82 0.0000% mcap 3.5% of flow Common Stock SEC:0000318154-26-000065:0
● SVP, Business Development · Executives · 2 May 2026 · AMGEN INC 108 shares @ US$329.82 0.0000% mcap 3.2% of flow Common Stock SEC:0000318154-26-000065:1
● SVP, Business Development · Executives · 16 Mar 2026 · AMGEN INC 707 shares @ US$366.21 14.7% of flow Common Stock SEC:0000318154-26-000030:0
◆ SVP, Business Development · Executives · 3 Mar 2026 · AMGEN INC 1,876 shares 0Common Stock SEC:0000318154-26-000019:0
▼ SVP, Business Development · Executives · 12 Nov 2025 · AMGEN INC 890 shares @ US$336.2422 13.9% of flow Common Stock SEC:0000318154-25-000082:0
● SVP, Business Development · Executives · 5 Nov 2025 · AMGEN INC 226 shares @ US$296.70 3.6% of flow Common Stock SEC:0000318154-25-000076:0
▼ SVP, Business Development · Executives · 5 Jun 2025 · AMGEN INC 1,500 shares @ US$289.68 28.8% of flow Common Stock SEC:0001127602-25-017018:0
◆ SVP, Business Development · Executives · 6 May 2025 · AMGEN INC 610 shares 0Common Stock SEC:0001127602-25-013784:0
● SVP, Business Development · Executives · 2 May 2025 · AMGEN INC 110 shares @ US$283.78 2.9% of flow Common Stock SEC:0001127602-25-013531:0
● SVP, Business Development · Executives · 2 May 2025 · AMGEN INC 104 shares @ US$283.78 2.8% of flow Common Stock SEC:0001127602-25-013531:1
● SVP, Business Development · Executives · 30 Apr 2025 · AMGEN INC 74 shares @ US$288.56 2.0% of flow Common Stock SEC:0001127602-25-013284:0
● SVP, Business Development · Executives · 17 Mar 2025 · AMGEN INC 489 shares @ US$313.71 15.0% of flow Common Stock SEC:0001127602-25-010058:0
◆ SVP, Business Development · Executives · 3 Mar 2025 · AMGEN INC 1,403 shares 0Common Stock SEC:0001127602-25-008426:0
● SVP, Business Development · Executives · 5 Nov 2024 · AMGEN INC 212 shares @ US$316.91 6.6% of flow Common Stock SEC:0001127602-24-026628:0
◆ SVP, Business Development · Executives · 7 May 2024 · AMGEN INC 532 shares 0Common Stock SEC:0001127602-24-014856:0
● SVP, Business Development · Executives · 5 May 2024 · AMGEN INC 41 shares @ US$311.29 1.3% of flow Common Stock SEC:0001127602-24-014510:0
● SVP, Business Development · Executives · 2 May 2024 · AMGEN INC 74 shares @ US$277.37 2.0% of flow Common Stock SEC:0001127602-24-014352:0
● SVP, Business Development · Executives · 30 Apr 2024 · AMGEN INC 48 shares @ US$276.38 1.3% of flow Common Stock SEC:0001127602-24-014027:0
● SVP, Business Development · Executives · 18 Mar 2024 · AMGEN INC 438 shares @ US$268.87 11.5% of flow Common Stock SEC:0001127602-24-010856:0
◆ SVP, Business Development · Executives · 6 Mar 2024 · AMGEN INC 1,256 shares 0Common Stock SEC:0001127602-24-009245:0
● SVP, Business Development · Executives · 5 Nov 2023 · AMGEN INC 173 shares @ US$269.86 4.7% of flow Common Stock SEC:0001127602-23-026977:0
● SVP, Business Development · Executives · 5 Nov 2023 · AMGEN INC 144 shares @ US$269.86 3.9% of flow Common Stock SEC:0001127602-23-026977:1
● SVP, Business Development · Executives · 5 May 2023 · AMGEN INC 39 shares @ US$231.89 0.9% of flow Common Stock SEC:0001127602-23-015048:0
◆ SVP, Business Development · Executives · 2 May 2023 · AMGEN INC 593 shares 0Common Stock SEC:0001127602-23-014609:0
● SVP, Business Development · Executives · 30 Apr 2023 · AMGEN INC 47 shares @ US$239.74 1.1% of flow Common Stock SEC:0001127602-23-014154:0
25 of 36 declarations
Load more (11 remaining) About Khosla Rachna Rachna Khosla is Senior Vice President and Head of Business Development at Amgen Inc. She is responsible for developing and implementing growth strategies, contributing to the expansion of the company's activities in the biopharmaceutical sector.